TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 4016545

Group type: EXPERIMENTAL
Intervention: Low-dose heparin treatment (5000 units twice daily subcutaneously)
Number of subjects: 176

Group type: COMPARATOR
Intervention: Low-dose heparin treatment supplemented with graded compression stockings
Number of subjects: 176
Study: 31391683

Group type: EXPERIMENTAL
Intervention: Riboflavin-assisted collagen cross-linking (C3R)
Number of subjects: 78
Study: 29748993

Group type: EXPERIMENTAL
Intervention: Standard Crisis Response Plan (S-CRP)
Number of subjects: 97

Group type: EXPERIMENTAL
Intervention: Enhanced Crisis Response Plan (E-CRP)
Number of subjects: 97

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 97
Study: 27958220

Group type: EXPERIMENTAL
Intervention: Tolterodine ER plus Tamsulosin
Number of subjects: 152

Group type: COMPARATOR
Intervention: Tolterodine ER alone
Number of subjects: 152
Study: 21887807

Group type: EXPERIMENTAL
Intervention: EstroG-100
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 20175014

Group type: EXPERIMENTAL
Intervention: Sports training (8 hours a week)
Number of subjects: 463

Group type: COMPARATOR
Intervention: Normotensive control group (no intervention)
Number of subjects: 463
Study: 17687276

Group type: EXPERIMENTAL
Intervention: 40 mg single-dose intravenous parecoxib
Number of subjects: 37
Study: 15642078

Group type: EXPERIMENTAL
Intervention: Insulin detemir
Number of subjects: 308

Group type: COMPARATOR
Intervention: NPH insulin
Number of subjects: 308
Study: 12650956

Group type: EXPERIMENTAL
Intervention: Fluvoxamine 300 mg/day
Number of subjects: 490

Group type: EXPERIMENTAL
Intervention: Paroxetine 40 mg/day
Number of subjects: 490

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 490

Group type: COMPARATOR
Intervention: Pindolol
Number of subjects: 490
Study: 10319772

Group type: EXPERIMENTAL
Intervention: Epidural analgesia with bupivacaine and fentanyl
Number of subjects: 715

Group type: COMPARATOR
Intervention: Patient-controlled intravenous analgesia with meperidine
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Nulliparity
Number of subjects: 715

Group type: EXPERIMENTAL
Intervention: Labor longer than 12 hours
Number of subjects: 715
Study: 8991563

Group type: EXPERIMENTAL
Intervention: CPAP breathing (10 cm H20)
Number of subjects: 10

Group type: COMPARATOR
Intervention: BiPAP breathing (10/4 cm H20)
Number of subjects: 10
Study: 31268268

Group type: EXPERIMENTAL
Intervention: Biphasic positive airway pressure (BPAP) applied for 3 days postoperatively
Number of subjects: 35

Group type: COMPARATOR
Intervention: Sham biphasic positive airway pressure (sham BPAP) applied for 3 days postoperatively
Number of subjects: 35
Study: 28726481

Group type: EXPERIMENTAL
Intervention: Trainer-led BA training
Number of subjects: 77

Group type: COMPARATOR
Intervention: Self-paced BA training
Number of subjects: 77
Study: 24894079

Group type: EXPERIMENTAL
Intervention: Negative pressure wound therapy (NPWT) with innovative negative pressure device (NPD)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Conventional methods of dressing
Number of subjects: 48
Study: 24442678

Group type: EXPERIMENTAL
Intervention: Virtual-reality training on a nephrectomy module
Number of subjects: 28

Group type: COMPARATOR
Intervention: Traditional black-box simulator training
Number of subjects: 28
Study: 22563244

Group type: EXPERIMENTAL
Intervention: Theophylline
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 19189676

Group type: EXPERIMENTAL
Intervention: Adhesive application (Scotchbond Multi‐Purpose Plus)
Number of subjects: 20

Group type: COMPARATOR
Intervention: No adhesive
Number of subjects: 20
Study: 16162997

Group type: EXPERIMENTAL
Intervention: Valacyclovir 500 mg BID for 7 days
Number of subjects: 29

Group type: COMPARATOR
Intervention: Placebo for 7 days
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Valacyclovir 1000 mg QD for 7 days
Number of subjects: 29
Study: 12663272

Group type: EXPERIMENTAL
Intervention: Randomized cocoa butter
Number of subjects: 17

Group type: COMPARATOR
Intervention: Cocoa butter (control)
Number of subjects: 17
Study: 10966246

Group type: EXPERIMENTAL
Intervention: Lorazepam (2 mg bolus plus 2 microg/kg/hr infusion for 4 hours)
Number of subjects: 9
Study: 8635728

Group type: EXPERIMENTAL
Intervention: Fluoroscopic guidance during Maloney dilation
Number of subjects: 83

Group type: COMPARATOR
Intervention: Blinded technique during Maloney dilation
Number of subjects: 83
Study: 1463176

Group type: EXPERIMENTAL
Intervention: Total intravenous anaesthesia with propofol
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional thiopentone/isoflurane/nitrous oxide anaesthesia
Number of subjects: 50
Study: 3937501

Group type: EXPERIMENTAL
Intervention: 10 mg capsule of nifedipine
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 2 capsules (20 mg) of nifedipine
Number of subjects: 47

Group type: COMPARATOR
Intervention: 20 mg tablet of nifedipine
Number of subjects: 47

Group type: COMPARATOR
Intervention: 40 mg tablet of nifedipine
Number of subjects: 47

Group type: COMPARATOR
Intervention: 60 mg tablet of nifedipine
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 2 X 20 mg daily of the tablet form of nifedipine
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: 2 X 40 mg of the nifedipine tablets
Number of subjects: 47
Study: 30006694

Group type: EXPERIMENTAL
Intervention: Centhaquin 0.015 mg/kg
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control (group CO)
Number of subjects: 20
Study: 29484808

Group type: EXPERIMENTAL
Intervention: Resveratrol supplementation
Number of subjects: 112

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 112
Study: 25457095

Group type: EXPERIMENTAL
Intervention: Love-inducing condition (dummy survey about love and romantic behavior)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control condition (neutral dummy survey on odd jobs)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Love-inducing condition
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 40
Study: 22712452

Group type: EXPERIMENTAL
Intervention: Variable Priority (VP) training
Number of subjects: 24

Group type: COMPARATOR
Intervention: Fixed Priority (FP) training
Number of subjects: 24
Study: 20378503

Group type: EXPERIMENTAL
Intervention: pegfilgrastim 6 mg
Number of subjects: 241

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 241
Study: 18022579

Group type: EXPERIMENTAL
Intervention: T cell depletion and cyclosporine (TCD)
Number of subjects: 404

Group type: COMPARATOR
Intervention: Methotrexate/cyclosporine (M/C)
Number of subjects: 404
Study: 15705376

Group type: EXPERIMENTAL
Intervention: N-acetyl-cysteine (NAC) 1.2 g/d with clomiphene citrate (CC) 100 mg/d for 5 days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Placebo with clomiphene citrate (CC) 100 mg/d for 5 days
Number of subjects: 150
Study: 12849761

Group type: EXPERIMENTAL
Intervention: Dopaminergic medication (L-Dopa), specific dosage and duration not mentioned
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Withdrawal of dopaminergic medication (off medication)
Number of subjects: 0
Study: 10533471

Group type: EXPERIMENTAL
Intervention: Formestane (250 mg intramuscularly every 2 weeks)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Megestrol acetate (160 mg orally daily)
Number of subjects: 177
Study: 8901143

Group type: EXPERIMENTAL
Intervention: Intravenous infusion of chlorprothixene (100 mg)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Oral aqueous solution of chlorprothixene (100 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Coated tablet of chlorprothixene (100 mg)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Suspension of chlorprothixene (100 mg)
Number of subjects: 8
Study: 1880883

Group type: EXPERIMENTAL
Intervention: Cocaine-exposed infants
Number of subjects: 554

Group type: COMPARATOR
Intervention: Unexposed infants
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Cocaine-exposed infants awaiting home and social evaluation or foster care placement
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Cocaine-exposed infants (specifically crack exposure)
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Cocaine-exposed infants (exposed to other illicit substances)
Number of subjects: 554

Group type: EXPERIMENTAL
Intervention: Cocaine-exposed infants (other forms of cocaine)
Number of subjects: 554
Study: 7104809

Group type: EXPERIMENTAL
Intervention: High volume low pressure cuffed tubes
Number of subjects: 56

Group type: COMPARATOR
Intervention: Low volume high pressure cuffed tubes
Number of subjects: 56
Study: 30590726

Group type: EXPERIMENTAL
Intervention: Percutaneous coronary intervention (PCI)
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass graft surgery (CABG)
Number of subjects: 611

Group type: COMPARATOR
Intervention: Medical treatment (MT)
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Overall mortality incidence
Number of subjects: 611

Group type: EXPERIMENTAL
Intervention: Primary endpoint (composite of overall death and myocardial infarction)
Number of subjects: 611
Study: 29385610

Group type: COMPARATOR
Intervention: Cottonseed hulls (CSH; control)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Ground woody plants (redberry, blueberry, one-seed, eastern red cedar, mesquite)
Number of subjects: 48
Study: 25778615

Group type: COMPARATOR
Intervention: Aripiprazole
Number of subjects: 17

Group type: COMPARATOR
Intervention: Haloperidol
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 23886884

Group type: EXPERIMENTAL
Intervention: Transurethral assistant LESS UVA (TALUVA)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Conventional LESS UVA (CLUVA)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 10
Study: 21840651

Group type: EXPERIMENTAL
Intervention: 350 mg carisoprodol
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 10 mg oxycodone
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: 350 mg carisoprodol followed by 10 mg oxycodone after 60 min
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 19703819

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg) plus atorvastatin (10 mg) daily for 6 months
Number of subjects: 50

Group type: COMPARATOR
Intervention: Aspirin (300 mg) plus atorvastatin (10 mg) daily for 6 months
Number of subjects: 50
Study: 18025296

Group type: EXPERIMENTAL
Intervention: Antecedent hypertension
Number of subjects: 14703

Group type: EXPERIMENTAL
Intervention: Elevated blood pressure (n=1226)
Number of subjects: 14703
Study: 15922565

Group type: EXPERIMENTAL
Intervention: Biological motion task
Number of subjects: 0

Group type: COMPARATOR
Intervention: Global-form task
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Social functioning
Number of subjects: 0
Study: 12543748

Group type: EXPERIMENTAL
Intervention: Inferior sector
Number of subjects: 19

Group type: COMPARATOR
Intervention: Superior sector
Number of subjects: 19
Study: 11038407

Group type: EXPERIMENTAL
Intervention: Isocapnic hypoxia with placebo
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Isocapnic hypoxia with beta-blockade
Number of subjects: 10

Group type: COMPARATOR
Intervention: Air breathing with placebo
Number of subjects: 10

Group type: COMPARATOR
Intervention: Air breathing with beta-blockade
Number of subjects: 10
Study: 9042316

Group type: EXPERIMENTAL
Intervention: Methioninase (5,000 units, 2-hour infusion)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Methioninase (10,000 units, 2-hour infusion)
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: Methioninase (20,000 units, 10-hour infusion)
Number of subjects: 3
Study: 1994422

Group type: EXPERIMENTAL
Intervention: Gadolinium-enhanced fat-saturation (FS) SE MR imaging
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Gadolinium-enhanced short TR/TE conventional SE
Number of subjects: 43

Group type: COMPARATOR
Intervention: Unenhanced short TR/TE conventional SE
Number of subjects: 43

Group type: COMPARATOR
Intervention: Unenhanced long TR/TE conventional SE
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Gadolinium-enhanced FS SE sequence
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Combined pre- and postcontrast short TR/TE FS SE images
Number of subjects: 43

Group type: EXPERIMENTAL
Intervention: Gadolinium-enhanced FS SE MR sequence
Number of subjects: 43
Study: 6147066

Group type: EXPERIMENTAL
Intervention: Therapist-directed prolonged exposure in vivo (PE)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Dynamically oriented supportive therapy (ST)
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Relaxation therapy (R)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Basal therapy (standardized information, self-exposure instructions, and anxiolytic medication)
Number of subjects: 73
Study: 31389340

Group type: EXPERIMENTAL
Intervention: Mobile Telesimulation Unit (MTU)
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Traditional face-to-face training
Number of subjects: 69

Group type: COMPARATOR
Intervention: Mobile Telesimulation Unit (MTU) and Traditional face-to-face training
Number of subjects: 69
Study: 31021852

Group type: EXPERIMENTAL
Intervention: Hair tenofovir (TFV) levels
Number of subjects: 71
Study: 27984542

Group type: EXPERIMENTAL
Intervention: Right anodal/left cathodal OP tDCS (2 mA, 12 min)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Left anodal/right cathodal OP tDCS (2 mA, 12 min)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham tDCS (15 s)
Number of subjects: 12
Study: 26146796

Group type: EXPERIMENTAL
Intervention: Dedicated stent introducer with a modified hybrid metal stent (DH group, n=16)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Conventional 8.5F biliary metal stent introducer with a fully covered metal stent (FC group, n=16)
Number of subjects: 32
Study: 24132900

Group type: EXPERIMENTAL
Intervention: Genome-Wide Association Study (GWAS) for atypical psychosis
Number of subjects: 47

Group type: COMPARATOR
Intervention: Gene-based analysis of SZ
Number of subjects: 47
Study: 21470906

Group type: EXPERIMENTAL
Intervention: Interactive e-drug calculations package
Number of subjects: 229
Study: 18343920

Group type: EXPERIMENTAL
Intervention: Different arm positions and radiographic beam orientations
Number of subjects: 30
Study: 16865863

Group type: EXPERIMENTAL
Intervention: 4 U/brow of botulinum toxin type A
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: 6 U/brow of botulinum toxin type A
Number of subjects: 40
Study: 12789898

Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study: 10685748

Group type: EXPERIMENTAL
Intervention: Braintree polyethylene glycol (PEG) laxative 17 g
Number of subjects: 151

Group type: COMPARATOR
Intervention: Dextrose placebo
Number of subjects: 151
Study: 9157586

Group type: EXPERIMENTAL
Intervention: rHDL (40 mg/kg, given as a 4 h infusion starting 3.5 h prior to LPS injection)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: rHDL
Number of subjects: 8
Study: 8146916

Group type: EXPERIMENTAL
Intervention: Kinetic positioning (KIN)
Number of subjects: 22
Study: 3453715

Group type: EXPERIMENTAL
Intervention: Ketotifen 2 mg/d with desensitization
Number of subjects: 48

Group type: COMPARATOR
Intervention: Specific hyposensitization treatment
Number of subjects: 48
Study: 31594193

Group type: EXPERIMENTAL
Intervention: Gait training with auditory feedback (30 minutes, 5 times a week, for 4 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gait training with auditory feedback
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional gait training (30 minutes, 5 times a week, for 4 weeks)
Number of subjects: 20
Study: 29707524

Group type: EXPERIMENTAL
Intervention: Catheter drainage combined with ozone (group II)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Catheter drainage alone (group I)
Number of subjects: 60
Study: 28033355

Group type: EXPERIMENTAL
Intervention: Intervention group 1 (lesson promoting active transport)
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Intervention group 2 (lesson promoting active transport + Facebook group membership)
Number of subjects: 441

Group type: EXPERIMENTAL
Intervention: Intervention group 1
Number of subjects: 441

Group type: COMPARATOR
Intervention: Control group (regular course 'Driving Licence at School')
Number of subjects: 441
Study: 24047189

Group type: EXPERIMENTAL
Intervention: Echocardiographically guided ibuprofen treatment
Number of subjects: 49

Group type: COMPARATOR
Intervention: Standard ibuprofen treatment
Number of subjects: 49
Study: 22486722

Group type: EXPERIMENTAL
Intervention: BioCell Collagen (BCC) 2 g
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 20507953

Group type: EXPERIMENTAL
Intervention: Intensive renal replacement therapy
Number of subjects: 415

Group type: COMPARATOR
Intervention: Less intensive renal replacement therapy
Number of subjects: 415
Study: 18783298

Group type: EXPERIMENTAL
Intervention: Lopinavir/ritonavir
Number of subjects: 53
Study: 15928285

Group type: EXPERIMENTAL
Intervention: PVI using radiofrequency ablation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Antiarrhythmic drug treatment
Number of subjects: 70
Study: 12709127

Group type: EXPERIMENTAL
Intervention: Tissue counter analysis combined with machine learning algorithms (CART and 1-NN)
Number of subjects: 369

Group type: EXPERIMENTAL
Intervention: Threshold value of 27.4% of elements suggestive for malignancy
Number of subjects: 369
Study: 10480205

Group type: EXPERIMENTAL
Intervention: High-dose (200 units Botox per leg)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Low-dose (100 units Botox per leg)
Number of subjects: 33
Study: 8911559

Group type: EXPERIMENTAL
Intervention: 30 mg paroxetine daily
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: 150 mg imipramine daily
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 1810657

Group type: EXPERIMENTAL
Intervention: xylitol (9.9%) and glycerol (20%) dentifrice
Number of subjects: 76

Group type: COMPARATOR
Intervention: sorbitol (28%) dentifrice
Number of subjects: 76

Group type: COMPARATOR
Intervention: comparison between xylitol/glycerol and sorbitol dentifrices
Number of subjects: 76
Study: 7362377

Group type: EXPERIMENTAL
Intervention: Meperidine hydrochloride (45 mg)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 31467191

Group type: EXPERIMENTAL
Intervention: CPAP withdrawal
Number of subjects: 70
Study: 29080198

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 60

Group type: COMPARATOR
Intervention: Sham-acupuncture
Number of subjects: 60
Study: 26013859

Group type: EXPERIMENTAL
Intervention: Modified double tracks anastomosis
Number of subjects: 763

Group type: COMPARATOR
Intervention: Esophageal gastric stump end-to-side anastomosis
Number of subjects: 763

Group type: COMPARATOR
Intervention: Radical total gastrectomy with esophageal jejunum Roux-en-Y anastomosis
Number of subjects: 763

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 763
Study: 22473731

Group type: EXPERIMENTAL
Intervention: self-help coping intervention (written self-help coping leaflet)
Number of subjects: 1958
Study: 17613971

Group type: EXPERIMENTAL
Intervention: Residential Treatment (RT)
Number of subjects: 160

Group type: COMPARATOR
Intervention: Outpatient Treatment (OP)
Number of subjects: 160
Study: 15462690

Group type: EXPERIMENTAL
Intervention: rosuvastatin 5 mg
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: rosuvastatin 10 mg
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: rosuvastatin 5 mg and 10 mg
Number of subjects: 135

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 135
Study: 11304773

Group type: EXPERIMENTAL
Intervention: Individualized education and coaching intervention (20-minute session)
Number of subjects: 67

Group type: COMPARATOR
Intervention: Standardized instruction on controlling pain (control group)
Number of subjects: 67
Study: 9382964

Group type: EXPERIMENTAL
Intervention: Growth hormone (0.1 IU x kg(‐1) x day(‐1)) for 4 days
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Glucocorticoid (50 mg/d) for 4 days
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Growth hormone plus glucocorticoid
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (saline injections for 4 days)
Number of subjects: 8
Study: 8390369

Group type: COMPARATOR
Intervention: 20 mg bisoprolol p.o. (pretreatment)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: 1200 mg celiprolol p.o.
Number of subjects: 8
Study: 3548809

Group type: EXPERIMENTAL
Intervention: Hypo-osmolar formulation using polyvinylpyrrolidone and hydroxyethyl cellulose
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Hypo-osmolar preparations of BJ6
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Hypromellose
Number of subjects: 2

Group type: COMPARATOR
Intervention: Iso-osmolar equivalents
Number of subjects: 2
Study: 30556583

Group type: EXPERIMENTAL
Intervention: Metacognitive Training for Depression (D-MCT)
Number of subjects: 84

Group type: COMPARATOR
Intervention: General Health Training (HT)
Number of subjects: 84
Study: 29986448

Group type: COMPARATOR
Intervention: Shooters with blood lead levels (BLL) ≥ 5 µg/dL
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Shooters
Number of subjects: 118

Group type: EXPERIMENTAL
Intervention: Shooters with BLL ≥ 10 µg/dL
Number of subjects: 118
Study: 27094107

Group type: EXPERIMENTAL
Intervention: Parenting program (ADAPT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 24428468

Group type: EXPERIMENTAL
Intervention: ABT-450/r (150 mg of ABT-450 and 100 mg of ritonavir) plus ribavirin for 8 weeks
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: ABT-450/r (150 mg of ABT-450 and 100 mg of ritonavir) plus ribavirin for 12 weeks
Number of subjects: 571

Group type: EXPERIMENTAL
Intervention: All treatment subgroups (various regimens of direct-acting antiviral agents and ribavirin)
Number of subjects: 571
Study: 22774206

Group type: EXPERIMENTAL
Intervention: Pazopanib 800 mg daily by mouth
Number of subjects: 15
Study: 21349048

Group type: EXPERIMENTAL
Intervention: YuangongCu365
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: TCu380A
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: MLCu375
Number of subjects: 0
Study: 17712755

Group type: EXPERIMENTAL
Intervention: Isoniazid monotherapy for 9 months (group A)
Number of subjects: 926

Group type: COMPARATOR
Intervention: Isoniazid plus rifampin for 4 months (group B)
Number of subjects: 926

Group type: COMPARATOR
Intervention: Isoniazid plus rifampin for 4 months (group C)
Number of subjects: 926

Group type: COMPARATOR
Intervention: Isoniazid plus rifampin for 3 months (group D)
Number of subjects: 926

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 926